These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8497942)

  • 1. [Contalgin and Doltard--2 different morphine depot preparations].
    Mikkelsen S
    Ugeskr Laeger; 1993 Apr; 155(14):1063. PubMed ID: 8497942
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the bioequivalence of two controlled-release formulations of morphine.
    Miller AJ; Smith KJ
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):138. PubMed ID: 8705092
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing pain with long-acting morphine.
    Ferrell BR
    Nursing; 1991 Oct; 21(10):34-40. PubMed ID: 1923023
    [No Abstract]   [Full Text] [Related]  

  • 4. [Respiratory depression following administration of morphine sulfate tablets with delayed action].
    Ned Tijdschr Geneeskd; 1989 May; 133(21):1095-6. PubMed ID: 2739791
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended-release morphine products.
    McCaffery M; Lochmann C
    Am J Nurs; 1996 Apr; 96(4):65. PubMed ID: 8600723
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advantages and problems of depot preparations].
    Abshagen U; Demmer F
    Med Klin; 1981 Aug; 76(18):484-90. PubMed ID: 7278789
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphine pharmacokinetics following intra-articular administration of a novel sustained release opioid (CDS-PM-101) for the relief of post-operative orthopaedic pain.
    Chen J; Cynkowski T; Guo H; Qin K; Cabral-Lilly D; Walters K; Ashton P
    J Control Release; 2005 Jan; 101(1-3):359-60. PubMed ID: 15822207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bioavailability of morphine after oral administration as retard tablets].
    Dittrich P; Semmelrock J; Wolf G; Beubler E
    Wien Klin Wochenschr; 1996; 108(5):147-52. PubMed ID: 8901129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synacthen-depot--an equivalent to systemic glucocorticosteroid therapy].
    Harnack K
    Dermatol Monatsschr; 1978 May; 164(5):382-9. PubMed ID: 210056
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches].
    Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B
    Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512
    [No Abstract]   [Full Text] [Related]  

  • 11. The therapeutic equivalence of i.m. and p.o. administration of morphine--1:3 or 1:6?
    Kaiko RF
    J Palliat Care; 1988 May; 4(1-2):64-6. PubMed ID: 2459360
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
    Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
    Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine in slow-release tablets.
    Drug Ther Bull; 1981 May; 19(11):44. PubMed ID: 7249942
    [No Abstract]   [Full Text] [Related]  

  • 14. [New morphine preparations with extended effect duration. 2 treatment observations].
    Kim DJ; Jankowska H; Dierke-Dzierzon C; Sturm M; Lindena G
    MMW Fortschr Med; 2000 May; 142(18):49. PubMed ID: 10851871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fentanyl by buccal administration. Fifty to hundred times stronger than morphine against pain].
    Taeron C
    Rev Infirm; 2002 Sep; (83):47-9. PubMed ID: 12380268
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of intravenous abuse of oral morphine sulfate.
    Welch JS
    Am Fam Physician; 1997 Oct; 56(5):1307-8. PubMed ID: 9381990
    [No Abstract]   [Full Text] [Related]  

  • 17. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet.
    Freye E; Levy JV; Braun D
    Pain Pract; 2007 Dec; 7(4):324-31. PubMed ID: 17986159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade.
    Bashaw ED; Kaiko RF; Grandy RP; Reder RF; Goldenheim PD
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):524-9. PubMed ID: 8520812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged release from the injection site of morphine from morphine esters in an oil vehicle given by intramuscular injection to pigs.
    Jørgensen A; Christrup LL; Fullerton A; Christensen CB; Bundgaard H
    Pharmacol Toxicol; 1994 Nov; 75(5):319-20. PubMed ID: 7870705
    [No Abstract]   [Full Text] [Related]  

  • 20. New horizons: sustained release morphine as agonist treatment.
    Woody GE
    Addiction; 2005 Dec; 100(12):1758-9. PubMed ID: 16367974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.